Nordic Pharma Consulting ApS — Credit Rating and Financial Key Figures

Nordic Pharma Consulting ApS (CVR number: 37368598) is a company from GLADSAXE. The company recorded a gross profit of 11.2 mDKK in 2023. The operating profit was 2047.6 kDKK, while net earnings were 1588.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was 26.7 %, which can be considered excellent and Return on Equity (ROE) was 46.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 45.9 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Nordic Pharma Consulting ApS's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.